Characteristics of 775 patients ≥70 years with PTCL according to CCI
Characteristic . | CCI = 0 (N = 304) . | CCI = 1 (N = 167) . | CCI > 1 (N = 304) . | P . |
---|---|---|---|---|
Sex | ||||
Male | 150 (49.3) | 91 (54.2) | 179 (58.7) | .061 |
Female | 154 (50.7) | 76 (45.5) | 125 (41.1) | |
Age, y, median (range) | 78 (70-102) | 78 (70-94) | 78 (70-95) | .723 |
Age > 80 y* | ||||
Yes | 114 (40.4) | 57 (20.2) | 111 (39.4) | .767 |
No | 190 (38.5) | 110 (22.3) | 193 (39.1) | |
Age groups* | ||||
70-74 | 87 (38.3) | 52 (22.9) | 88 (38.8) | .918 |
75-84 | 153 (39.6) | 84 (21.8) | 149 (38.6) | |
>84 | 64 (39.3) | 31 (19.0) | 68 (41.7) | |
Ann Arbor stage | ||||
I-II | 98 (34.5) | 43 (27.4) | 93 (33.2) | .293 |
III-IV | 186 (65.5) | 114 (72.6) | 187 (66.8) | |
Treatment | ||||
Yes | 176 (58.9) | 102 (61.4) | 168 (56.4) | .559 |
No | 123 (41.1) | 64 (38.6) | 130 (43.6) | |
Histologic subtypes | ||||
AITL | 91 (29.9) | 42 (25.1) | 73 (24.0) | .563 |
ALCL | 36 (11.8) | 27 (16.2) | 42 (13.8) | |
EATL | 14 (4.6) | 4 (2.4) | 7 (2.3) | |
Hepatosplenic | 3 (1.0) | 1 (0.6) | 2 (0.7) | |
NK/T cell | 22 (7.2) | 11 (6.6) | 20 (6.6) | |
PTCL, NOS | 138 (45.4) | 82 (49.1) | 160 (52.6) |
Characteristic . | CCI = 0 (N = 304) . | CCI = 1 (N = 167) . | CCI > 1 (N = 304) . | P . |
---|---|---|---|---|
Sex | ||||
Male | 150 (49.3) | 91 (54.2) | 179 (58.7) | .061 |
Female | 154 (50.7) | 76 (45.5) | 125 (41.1) | |
Age, y, median (range) | 78 (70-102) | 78 (70-94) | 78 (70-95) | .723 |
Age > 80 y* | ||||
Yes | 114 (40.4) | 57 (20.2) | 111 (39.4) | .767 |
No | 190 (38.5) | 110 (22.3) | 193 (39.1) | |
Age groups* | ||||
70-74 | 87 (38.3) | 52 (22.9) | 88 (38.8) | .918 |
75-84 | 153 (39.6) | 84 (21.8) | 149 (38.6) | |
>84 | 64 (39.3) | 31 (19.0) | 68 (41.7) | |
Ann Arbor stage | ||||
I-II | 98 (34.5) | 43 (27.4) | 93 (33.2) | .293 |
III-IV | 186 (65.5) | 114 (72.6) | 187 (66.8) | |
Treatment | ||||
Yes | 176 (58.9) | 102 (61.4) | 168 (56.4) | .559 |
No | 123 (41.1) | 64 (38.6) | 130 (43.6) | |
Histologic subtypes | ||||
AITL | 91 (29.9) | 42 (25.1) | 73 (24.0) | .563 |
ALCL | 36 (11.8) | 27 (16.2) | 42 (13.8) | |
EATL | 14 (4.6) | 4 (2.4) | 7 (2.3) | |
Hepatosplenic | 3 (1.0) | 1 (0.6) | 2 (0.7) | |
NK/T cell | 22 (7.2) | 11 (6.6) | 20 (6.6) | |
PTCL, NOS | 138 (45.4) | 82 (49.1) | 160 (52.6) |
Data are presented as no. (%) unless indicated otherwise.
Percentage counted for each row.